Literature DB >> 16151884

Factors modifying the association between hormone-replacement therapy and breast cancer risk.

Beate Pesch1, Yon Ko, Hiltrud Brauch, Ute Hamann, Volker Harth, Sylvia Rabstein, Christiane Pierl, Hans-Peter Fischer, Christian Baisch, Christina Justenhoven, Ulrich Ranft, Thomas Brüning.   

Abstract

OBJECTIVES: Hormone-replacement therapy (HRT) is an established risk factor for breast cancer. HRT users are different from non-users with respect to socio-economic and other characteristics. There may be women where the HRT-related risk could be modulated by other factors.
METHODS: We conducted a population-based case-control study with 688 breast cancer cases and 724 controls to characterize HRT users and to estimate odds ratios (OR) and 95% confidence intervals (CI) for HRT use and potentially risk modifying factors.
RESULTS: In women aged 50 years and older, 58% of controls and 61% of cases ever used HRT. Among women in natural menopause, HRT use for 10 years and more years was associated with an increased breast cancer risk (OR 1.79, 95% CI, 1.12-2.87), but not among women in surgical menopause (OR 0.61, 95% CI, 0.09-4.17). In the subgroup of women with a positive family history of breast cancer, each year of HRT use increased the risk by 1.22 (95% CI, 1.02-1.47). Another subgroup comprised women with at least 10 diagnostic mammograms (OR 4.04, 95% CI, 1.10-14.81 for using HRT 10 or more years).
CONCLUSIONS: Long-term HRT use was associated with a breast cancer risk in women with natural menopause. Our findings suggest that this risk may be increased in women with a positive family history of breast cancer and in women who received frequent diagnostic mammographic screens.

Entities:  

Mesh:

Year:  2005        PMID: 16151884     DOI: 10.1007/s10654-005-0032-0

Source DB:  PubMed          Journal:  Eur J Epidemiol        ISSN: 0393-2990            Impact factor:   8.082


  32 in total

1.  Hormone replacement therapy and cancer risk: a systematic analysis from a network of case-control studies.

Authors:  Esteve Fernandez; Silvano Gallus; Cristina Bosetti; Silvia Franceschi; Eva Negri; Carlo La Vecchia
Journal:  Int J Cancer       Date:  2003-06-20       Impact factor: 7.396

2.  A meta-analysis of the effect of estrogen replacement therapy on the risk of breast cancer.

Authors:  K K Steinberg; S B Thacker; S J Smith; D F Stroup; M M Zack; W D Flanders; R L Berkelman
Journal:  JAMA       Date:  1991-04-17       Impact factor: 56.272

3.  Attributable risks for breast cancer in Italy: education, family history and reproductive and hormonal factors.

Authors:  A Tavani; C Braga; C La Vecchia; E Negri; A Russo; S Franceschi
Journal:  Int J Cancer       Date:  1997-01-17       Impact factor: 7.396

4.  Does menopausal hormone replacement therapy interact with known factors to increase risk of breast cancer?

Authors:  Giske Ursin; Chiu-Chen Tseng; Annlia Paganini-Hill; Shelley Enger; Peggy C Wan; Silvia Formenti; Malcolm C Pike; Ronald K Ross
Journal:  J Clin Oncol       Date:  2002-02-01       Impact factor: 44.544

5.  Hormone replacement therapy containing progestins and given continuously increases breast carcinoma risk in Sweden.

Authors:  Håkan L Olsson; Christian Ingvar; Anna Bladström
Journal:  Cancer       Date:  2003-03-15       Impact factor: 6.860

6.  Proliferative effects of combination estrogen and progesterone replacement therapy on the normal postmenopausal mammary gland in a murine model.

Authors:  A M Raafat; L J Hofseth; S Z Haslam
Journal:  Am J Obstet Gynecol       Date:  2001-02       Impact factor: 8.661

7.  Breast cancer worry and mammography use by women with and without a family history in a population-based sample.

Authors:  M Robyn Andersen; Robert Smith; H Meischke; D Bowen; N Urban
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-04       Impact factor: 4.254

8.  Direct action of 17 beta-estradiol on mouse mammary ducts analyzed by sustained release implants and steroid autoradiography.

Authors:  C W Daniel; G B Silberstein; P Strickland
Journal:  Cancer Res       Date:  1987-11-15       Impact factor: 12.701

9.  Combined effect of oral contraceptive use and hormone replacement therapy on breast cancer risk in postmenopausal women.

Authors:  Sandra A Norman; Jesse A Berlin; Anita L Weber; Brian L Strom; Janet R Daling; Linda K Weiss; Polly A Marchbanks; Leslie Bernstein; Lynda F Voigt; Jill A McDonald; Giske Ursin; Jonathan M Liff; Ronald T Burkman; Kathleen E Malone; Michael S Simon; Suzanne G Folger; Dennis Deapen; Phyllis A Wingo; Robert Spirtas
Journal:  Cancer Causes Control       Date:  2003-12       Impact factor: 2.506

10.  Patterns of use of hormone replacement therapy in one million women in Britain, 1996-2000.

Authors: 
Journal:  BJOG       Date:  2002-12       Impact factor: 6.531

View more
  12 in total

1.  Estrogen metabolism and exposure in a genotypic-phenotypic model for breast cancer risk prediction.

Authors:  Philip S Crooke; Christina Justenhoven; Hiltrud Brauch; Sheila Dawling; Nady Roodi; Kathryn S P Higginbotham; W Dale Plummer; Peggy A Schuyler; Melinda E Sanders; David L Page; Jeffrey R Smith; William D Dupont; Fritz F Parl
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2011-05-24       Impact factor: 4.254

2.  CYP2B6*6 is associated with increased breast cancer risk.

Authors:  Christina Justenhoven; Daniela Pentimalli; Sylvia Rabstein; Volker Harth; Anne Lotz; Beate Pesch; Thomas Brüning; Thilo Dörk; Peter Schürmann; Natalia Bogdanova; Tjoung-Won Park-Simon; Fergus J Couch; Janet E Olson; Peter A Fasching; Matthias W Beckmann; Lothar Häberle; Arif Ekici; Per Hall; Kamilla Czene; Janjun Liu; Jingmei Li; Christian Baisch; Ute Hamann; Yon-Dschun Ko; Hiltrud Brauch
Journal:  Int J Cancer       Date:  2013-07-30       Impact factor: 7.396

3.  Association of genetic variation in mitotic kinases with breast cancer risk.

Authors:  Xianshu Wang; Zachary S Fredericksen; Robert A Vierkant; Matthew L Kosel; V Shane Pankratz; James R Cerhan; Christina Justenhoven; Hiltrud Brauch; Janet E Olson; Fergus J Couch
Journal:  Breast Cancer Res Treat       Date:  2009-04-30       Impact factor: 4.872

4.  Hormone replacement therapy, family history, and breast cancer risk among postmenopausal women.

Authors:  Robert Gramling; Charles B Eaton; Kenneth J Rothman; Howard Cabral; Rebecca A Silliman; Timothy L Lash
Journal:  Epidemiology       Date:  2009-09       Impact factor: 4.822

5.  Making sense of cancer risk calculators on the web.

Authors:  Andrea Gurmankin Levy; Seema S Sonnad; Jibby E Kurichi; Melani Sherman; Katrina Armstrong
Journal:  J Gen Intern Med       Date:  2008-01-11       Impact factor: 5.128

6.  11q13 is a susceptibility locus for hormone receptor positive breast cancer.

Authors:  Diether Lambrechts; Therese Truong; Christina Justenhoven; Manjeet K Humphreys; Jean Wang; John L Hopper; Gillian S Dite; Carmel Apicella; Melissa C Southey; Marjanka K Schmidt; Annegien Broeks; Sten Cornelissen; Richard van Hien; Elinor Sawyer; Ian Tomlinson; Michael Kerin; Nicola Miller; Roger L Milne; M Pilar Zamora; José Ignacio Arias Pérez; Javier Benítez; Ute Hamann; Yon-Dschun Ko; Thomas Brüning; Jenny Chang-Claude; Ursel Eilber; Rebecca Hein; Stefan Nickels; Dieter Flesch-Janys; Shan Wang-Gohrke; Esther M John; Alexander Miron; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Georgia Chenevix-Trench; Jonathan Beesley; Xiaoqing Chen; Florence Menegaux; Emilie Cordina-Duverger; Chen-Yang Shen; Jyh-Cherng Yu; Pei-Ei Wu; Ming-Feng Hou; Irene L Andrulis; Teresa Selander; Gord Glendon; Anna Marie Mulligan; Hoda Anton-Culver; Argyrios Ziogas; Kenneth R Muir; Artitaya Lophatananon; Suthee Rattanamongkongul; Puttisak Puttawibul; Michael Jones; Nicholas Orr; Alan Ashworth; Anthony Swerdlow; Gianluca Severi; Laura Baglietto; Graham Giles; Melissa Southey; Federik Marmé; Andreas Schneeweiss; Christof Sohn; Barbara Burwinkel; Betul T Yesilyurt; Patrick Neven; Robert Paridaens; Hans Wildiers; Hermann Brenner; Heiko Müller; Volker Arndt; Christa Stegmaier; Alfons Meindl; Sarah Schott; Claus R Bartram; Rita K Schmutzler; Angela Cox; Ian W Brock; Graeme Elliott; Simon S Cross; Peter A Fasching; Ruediger Schulz-Wendtland; Arif B Ekici; Matthias W Beckmann; Olivia Fletcher; Nichola Johnson; Isabel Dos Santos Silva; Julian Peto; Heli Nevanlinna; Taru A Muranen; Kristiina Aittomäki; Carl Blomqvist; Thilo Dörk; Peter Schürmann; Michael Bremer; Peter Hillemanns; Natalia V Bogdanova; Natalia N Antonenkova; Yuri I Rogov; Johann H Karstens; Elza Khusnutdinova; Marina Bermisheva; Darya Prokofieva; Shamil Gancev; Anna Jakubowska; Jan Lubinski; Katarzyna Jaworska; Katarzyna Durda; Børge G Nordestgaard; Stig E Bojesen; Charlotte Lanng; Arto Mannermaa; Vesa Kataja; Veli-Matti Kosma; Jaana M Hartikainen; Paolo Radice; Paolo Peterlongo; Siranoush Manoukian; Loris Bernard; Fergus J Couch; Janet E Olson; Xianshu Wang; Zachary Fredericksen; Grethe Grenaker Alnaes; Vessela Kristensen; Anne-Lise Børresen-Dale; Peter Devilee; Robert A E M Tollenaar; Caroline M Seynaeve; Maartje J Hooning; Montserrat García-Closas; Stephen J Chanock; Jolanta Lissowska; Mark E Sherman; Per Hall; Jianjun Liu; Kamila Czene; Daehee Kang; Keun-Young Yoo; Dong-Young Noh; Annika Lindblom; Sara Margolin; Alison M Dunning; Paul D P Pharoah; Douglas F Easton; Pascal Guénel; Hiltrud Brauch
Journal:  Hum Mutat       Date:  2012-04-30       Impact factor: 4.878

7.  Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies.

Authors:  Xiaohong R Yang; Jenny Chang-Claude; Ellen L Goode; Fergus J Couch; Heli Nevanlinna; Roger L Milne; Mia Gaudet; Marjanka K Schmidt; Annegien Broeks; Angela Cox; Peter A Fasching; Rebecca Hein; Amanda B Spurdle; Fiona Blows; Kristy Driver; Dieter Flesch-Janys; Judith Heinz; Peter Sinn; Alina Vrieling; Tuomas Heikkinen; Kristiina Aittomäki; Päivi Heikkilä; Carl Blomqvist; Jolanta Lissowska; Beata Peplonska; Stephen Chanock; Jonine Figueroa; Louise Brinton; Per Hall; Kamila Czene; Keith Humphreys; Hatef Darabi; Jianjun Liu; Laura J Van 't Veer; Flora E van Leeuwen; Irene L Andrulis; Gord Glendon; Julia A Knight; Anna Marie Mulligan; Frances P O'Malley; Nayana Weerasooriya; Esther M John; Matthias W Beckmann; Arndt Hartmann; Sebastian B Weihbrecht; David L Wachter; Sebastian M Jud; Christian R Loehberg; Laura Baglietto; Dallas R English; Graham G Giles; Catriona A McLean; Gianluca Severi; Diether Lambrechts; Thijs Vandorpe; Caroline Weltens; Robert Paridaens; Ann Smeets; Patrick Neven; Hans Wildiers; Xianshu Wang; Janet E Olson; Victoria Cafourek; Zachary Fredericksen; Matthew Kosel; Celine Vachon; Helen E Cramp; Daniel Connley; Simon S Cross; Sabapathy P Balasubramanian; Malcolm W R Reed; Thilo Dörk; Michael Bremer; Andreas Meyer; Johann H Karstens; Aysun Ay; Tjoung-Won Park-Simon; Peter Hillemanns; Jose Ignacio Arias Pérez; Primitiva Menéndez Rodríguez; Pilar Zamora; Javier Benítez; Yon-Dschun Ko; Hans-Peter Fischer; Ute Hamann; Beate Pesch; Thomas Brüning; Christina Justenhoven; Hiltrud Brauch; Diana M Eccles; William J Tapper; Sue M Gerty; Elinor J Sawyer; Ian P Tomlinson; Angela Jones; Michael Kerin; Nicola Miller; Niall McInerney; Hoda Anton-Culver; Argyrios Ziogas; Chen-Yang Shen; Chia-Ni Hsiung; Pei-Ei Wu; Show-Lin Yang; Jyh-Cherng Yu; Shou-Tung Chen; Giu-Cheng Hsu; Christopher A Haiman; Brian E Henderson; Loic Le Marchand; Laurence N Kolonel; Annika Lindblom; Sara Margolin; Anna Jakubowska; Jan Lubiński; Tomasz Huzarski; Tomasz Byrski; Bohdan Górski; Jacek Gronwald; Maartje J Hooning; Antoinette Hollestelle; Ans M W van den Ouweland; Agnes Jager; Mieke Kriege; Madeleine M A Tilanus-Linthorst; Margriet Collée; Shan Wang-Gohrke; Katri Pylkäs; Arja Jukkola-Vuorinen; Kari Mononen; Mervi Grip; Pasi Hirvikoski; Robert Winqvist; Arto Mannermaa; Veli-Matti Kosma; Jaana Kauppinen; Vesa Kataja; Päivi Auvinen; Ylermi Soini; Reijo Sironen; Stig E Bojesen; David Dynnes Ørsted; Diljit Kaur-Knudsen; Henrik Flyger; Børge G Nordestgaard; Helene Holland; Georgia Chenevix-Trench; Siranoush Manoukian; Monica Barile; Paolo Radice; Susan E Hankinson; David J Hunter; Rulla Tamimi; Suleeporn Sangrajrang; Paul Brennan; James McKay; Fabrice Odefrey; Valerie Gaborieau; Peter Devilee; P E A Huijts; R A E M Tollenaar; C Seynaeve; Gillian S Dite; Carmel Apicella; John L Hopper; Fleur Hammet; Helen Tsimiklis; Letitia D Smith; Melissa C Southey; Manjeet K Humphreys; Douglas Easton; Paul Pharoah; Mark E Sherman; Montserrat Garcia-Closas
Journal:  J Natl Cancer Inst       Date:  2010-12-29       Impact factor: 13.506

8.  Family history, genetic testing, and clinical risk prediction: pooled analysis of CHEK2 1100delC in 1,828 bilateral breast cancers and 7,030 controls.

Authors:  Olivia Fletcher; Nichola Johnson; Isabel Dos Santos Silva; Outi Kilpivaara; Kristiina Aittomäki; Carl Blomqvist; Heli Nevanlinna; Marijke Wasielewski; Hanne Meijers-Heijerboer; Annegien Broeks; Marjanka K Schmidt; Laura J Van't Veer; Michael Bremer; Thilo Dörk; Elena V Chekmariova; Anna P Sokolenko; Evgeny N Imyanitov; Ute Hamann; Muhammad U Rashid; Hiltrud Brauch; Christina Justenhoven; Alan Ashworth; Julian Peto
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2009-01       Impact factor: 4.254

9.  The UGT1A6_19_GG genotype is a breast cancer risk factor.

Authors:  Christina Justenhoven; Ofure Obazee; Stefan Winter; Sylvia Rabstein; Anne Lotz; Volker Harth; Beate Pesch; Thomas Brüning; Christian Baisch; Jaana M Hartikainen; Arto Mannermaa; Veli-Matti Kosma; Vesa Kataja; Robert Winqvist; Katri Pylkäs; Arja Jukkola-Vuorinen; Mervi Grip; Peter A Fasching; Matthias Beckmann; Arif B Ekici; Alexander Hein; Per Hall; Jingmei Li; Jenny Chang-Claude; Dieter Flesch-Janys; Petra Seibold; Anja Rudolph; Ute Hamann; Yon-Dschun Ko; Hiltrud Brauch
Journal:  Front Genet       Date:  2013-06-11       Impact factor: 4.599

10.  Polymorphisms of Phase I and Phase II Enzymes and Breast Cancer Risk.

Authors:  Christina Justenhoven
Journal:  Front Genet       Date:  2012-11-28       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.